[
  {
    "title": "A股异动 | 维康药业(300878.SZ)大涨14% 银黄吸入溶液对于新冠等多种病毒感染具有显著治疗作用",
    "href": "http://stock.jrj.com.cn/2022/12/29101337245392.shtml",
    "datetime": "2022-12-29 10:13:55",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：就申请发行可转债、收到审核问询函",
    "href": "http://stock.jrj.com.cn/2022/12/20152037225453.shtml",
    "datetime": "2022-12-20 15:20:33",
    "code": "300878"
  },
  {
    "title": "维康药业股东减持14.81万股 套现约422.33万 2022年前三季度公司净利9393.09万",
    "href": "http://stock.jrj.com.cn/2022/12/15203337216272.shtml",
    "datetime": "2022-12-15 20:33:13",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：高管戴德雄完成减持14.81万股",
    "href": "http://stock.jrj.com.cn/2022/12/15154437215084.shtml",
    "datetime": "2022-12-15 15:44:07",
    "code": "300878"
  },
  {
    "title": "龙虎榜 | 大港股份获净买入8446万元；维康药业昨日涨停后今日暴跌，游资苏南帮、上塘路“被埋”",
    "href": "http://stock.jrj.com.cn/2022/12/14180437212532.shtml",
    "datetime": "2022-12-14 18:04:54",
    "code": "300878"
  },
  {
    "title": "【龙虎榜】维康药业12月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/14180037212506.shtml",
    "datetime": "2022-12-14 18:00:23",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：可转债发行申请获深交所受理",
    "href": "http://stock.jrj.com.cn/2022/12/05165137189047.shtml",
    "datetime": "2022-12-05 16:51:03",
    "code": "300878"
  },
  {
    "title": "【龙虎榜】维康药业11月2日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/02180037107208.shtml",
    "datetime": "2022-11-02 18:00:41",
    "code": "300878"
  },
  {
    "title": "中药板块低开高走，维康药业涨超13%",
    "href": "http://stock.jrj.com.cn/2022/11/02102737105573.shtml",
    "datetime": "2022-11-02 10:27:07",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：刘忠姣质押987.2万股",
    "href": "http://stock.jrj.com.cn/2022/10/20214937071538.shtml",
    "datetime": "2022-10-20 21:49:12",
    "code": "300878"
  },
  {
    "title": "最新龙虎榜：机构买入安图生物超2亿，知名游资买入维康药业",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/19072337065683.shtml",
    "datetime": "2022-10-19 07:23:30",
    "code": "300878"
  },
  {
    "title": "【龙虎榜】维康药业10月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/10/18180037064562.shtml",
    "datetime": "2022-10-18 18:00:40",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：拟发行可转债募资不超6.8亿元、用于医药大健康产业园二期项目等等",
    "href": "http://stock.jrj.com.cn/2022/10/11223437048478.shtml",
    "datetime": "2022-10-11 22:34:13",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)半年度净利润5698.57万元 同比下降10.64%",
    "href": "http://stock.jrj.com.cn/2022/08/29175336948040.shtml",
    "datetime": "2022-08-29 17:53:42",
    "code": "300878"
  },
  {
    "title": "维康药业：拟增资扩股收购杭州海善70%股权",
    "href": "http://stock.jrj.com.cn/2022/07/18203436822519.shtml",
    "datetime": "2022-07-18 20:34:55",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：拟以增资扩股方式收购杭州海善70%股权",
    "href": "http://stock.jrj.com.cn/2022/07/18201836822478.shtml",
    "datetime": "2022-07-18 20:18:46",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：收到与收益相关的政府补助1089.13万元",
    "href": "http://stock.jrj.com.cn/2022/06/30190836772457.shtml",
    "datetime": "2022-06-30 19:08:34",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：副总经理戴德雄拟减持不超0.1%股份",
    "href": "http://stock.jrj.com.cn/2022/06/24172936757137.shtml",
    "datetime": "2022-06-24 17:29:07",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)2021年度权益分派10转8派5.4元 股权登记日为6月16日",
    "href": "http://stock.jrj.com.cn/2022/06/10205936720615.shtml",
    "datetime": "2022-06-10 20:59:44",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：银黄滴丸治疗复发性口腔溃疡(上焦实热证)完成Ⅱ期临床试验",
    "href": "http://stock.jrj.com.cn/2022/03/28184635911800.shtml",
    "datetime": "2022-03-28 18:46:11",
    "code": "300878"
  },
  {
    "title": "维康药业：公司研究院被认定为省重点企业研究院 对公司长期发展有积极作用",
    "href": "http://stock.jrj.com.cn/2022/01/07134534133131.shtml",
    "datetime": "2022-01-07 13:45:19",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：公司研究院被认定为省重点企业研究院",
    "href": "http://stock.jrj.com.cn/2022/01/07115634132879.shtml",
    "datetime": "2022-01-07 11:56:46",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：部分募投项目延期",
    "href": "http://stock.jrj.com.cn/2021/12/30184234087677.shtml",
    "datetime": "2021-12-30 18:42:21",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：拟使用超募资金5500万元用于永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/12/14190134015417.shtml",
    "datetime": "2021-12-14 19:01:15",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：已持有瓯江胶囊70%股权",
    "href": "http://stock.jrj.com.cn/2021/09/15161133439834.shtml",
    "datetime": "2021-09-15 16:11:30",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：监事俞晓红亲属短线交易公司股票",
    "href": "http://stock.jrj.com.cn/2021/09/07161733398663.shtml",
    "datetime": "2021-09-07 16:17:42",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：签署技术转让及技术服务合同",
    "href": "http://stock.jrj.com.cn/2021/09/01205733369549.shtml",
    "datetime": "2021-09-01 20:57:31",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)半年度净利润6377.11万元 同比增长9.87%",
    "href": "http://stock.jrj.com.cn/2021/08/27152233333025.shtml",
    "datetime": "2021-08-27 15:22:10",
    "code": "300878"
  },
  {
    "title": "维康药业2021年半年度净利6377.11万元 同比净利增加9.87%",
    "href": "http://stock.jrj.com.cn/2021/08/26211733326995.shtml",
    "datetime": "2021-08-26 21:17:44",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：与北京盈科瑞签署战略合作协议暨1.1类中药创新药项目合作",
    "href": "http://stock.jrj.com.cn/2021/06/30214433023787.shtml",
    "datetime": "2021-06-30 21:44:33",
    "code": "300878"
  },
  {
    "title": "维康药业：目前公司生产经营正常 不存在股价破发情况",
    "href": "http://stock.jrj.com.cn/2021/06/01183532858325.shtml",
    "datetime": "2021-06-01 18:35:14",
    "code": "300878"
  },
  {
    "title": "维康药业：益母草软胶囊可用于产后恶露不绝 症见产后出血时间过长",
    "href": "http://stock.jrj.com.cn/2021/06/01183332858328.shtml",
    "datetime": "2021-06-01 18:33:36",
    "code": "300878"
  },
  {
    "title": "维康药业：目前 公司暂未涉及出口业务",
    "href": "http://stock.jrj.com.cn/2021/06/01183232858305.shtml",
    "datetime": "2021-06-01 18:32:06",
    "code": "300878"
  },
  {
    "title": "维康药业：公司高度重视研发投入和人才引进 先后成立了多个科研平台",
    "href": "http://stock.jrj.com.cn/2021/06/01183132858304.shtml",
    "datetime": "2021-06-01 18:31:41",
    "code": "300878"
  },
  {
    "title": "维康药业：目前 公司尚不涉及辅助生殖业务",
    "href": "http://stock.jrj.com.cn/2021/06/01172432857707.shtml",
    "datetime": "2021-06-01 17:24:51",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)2020年度权益分派10派10元 股权登记日为5月28日",
    "href": "http://stock.jrj.com.cn/2021/05/21212832795237.shtml",
    "datetime": "2021-05-21 21:28:27",
    "code": "300878"
  },
  {
    "title": "维康药业：公司旗下浙江维康中药有限公司主要经营范围为药品、保健食品的生产和销售",
    "href": "http://stock.jrj.com.cn/2021/05/14104232753828.shtml",
    "datetime": "2021-05-14 10:42:44",
    "code": "300878"
  },
  {
    "title": "维康药业：公司一直高度重视投资者关系管理、市值管理等工作公司有团队专门负责相关工作",
    "href": "http://stock.jrj.com.cn/2021/04/21094032414518.shtml",
    "datetime": "2021-04-21 09:40:32",
    "code": "300878"
  },
  {
    "title": "维康药业2020年净利增长7.78% 董事长刘忠良薪酬70.11万",
    "href": "http://stock.jrj.com.cn/2021/04/01154032263182.shtml",
    "datetime": "2021-04-01 15:40:42",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)2020年度净利润升7.78%至1.36亿元 拟10派10元",
    "href": "http://stock.jrj.com.cn/2021/03/31005132251256.shtml",
    "datetime": "2021-03-31 00:51:39",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)获得金钱草胶囊和肝苏胶囊补充申请批件",
    "href": "http://stock.jrj.com.cn/2021/03/02115532056333.shtml",
    "datetime": "2021-03-02 11:55:28",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：103.691万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/03/01185132051703.shtml",
    "datetime": "2021-03-01 18:51:50",
    "code": "300878"
  },
  {
    "title": "维康药业股东刘忠姣质押548.45万股 用于个人资金需求",
    "href": "http://stock.jrj.com.cn/2021/02/03212931845019.shtml",
    "datetime": "2021-02-03 21:29:22",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：7月1日以来累计获得政府补助2034.36万元",
    "href": "http://stock.jrj.com.cn/2020/12/18193231520397.shtml",
    "datetime": "2020-12-18 19:32:40",
    "code": "300878"
  },
  {
    "title": "维康药业股东顺泽投资质押155万股 用于融资担保",
    "href": "http://stock.jrj.com.cn/2020/12/10193731458806.shtml",
    "datetime": "2020-12-10 19:37:22",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：股东顺泽投资质押155万股",
    "href": "http://stock.jrj.com.cn/2020/12/10154731456229.shtml",
    "datetime": "2020-12-10 15:47:51",
    "code": "300878"
  },
  {
    "title": "维康药业：公司具有技术和研发、质量、产品、团队等多方位优势",
    "href": "http://stock.jrj.com.cn/2020/11/13130831274839.shtml",
    "datetime": "2020-11-13 13:08:10",
    "code": "300878"
  },
  {
    "title": "维康药业前三季度净利8929.77万增长6.89% 利息收入增加",
    "href": "http://stock.jrj.com.cn/2020/10/28181631151693.shtml",
    "datetime": "2020-10-28 18:16:51",
    "code": "300878"
  },
  {
    "title": "维康药业：拟与自然人共同投资设立控股子公司 实施业务整合",
    "href": "http://stock.jrj.com.cn/2020/10/16154031067746.shtml",
    "datetime": "2020-10-16 15:40:50",
    "code": "300878"
  },
  {
    "title": "维康药业(300878.SZ)：拟出资1400万元新设印刷控股子公司",
    "href": "http://stock.jrj.com.cn/2020/10/15125531059349.shtml",
    "datetime": "2020-10-15 12:55:41",
    "code": "300878"
  },
  {
    "title": "维康药业：公司在新药研发方面取得重大进展 并完成一些中短期项目 如仿制药开发、重点产品的二次开发研究等",
    "href": "http://stock.jrj.com.cn/2020/09/25100630833836.shtml",
    "datetime": "2020-09-25 10:06:42",
    "code": "300878"
  },
  {
    "title": "【龙虎榜】维康药业8月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/08/24180030577300.shtml",
    "datetime": "2020-08-24 18:00:54",
    "code": "300878"
  },
  {
    "title": "维康药业成功登陆创业板 开盘大涨86.26%",
    "href": "http://stock.jrj.com.cn/2020/08/24142730575301.shtml",
    "datetime": "2020-08-24 14:27:00",
    "code": "300878"
  },
  {
    "title": "维康药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/08/21021030552581.shtml",
    "datetime": "2020-08-21 02:10:00",
    "code": "300878"
  },
  {
    "title": "维康药业IPO：唯一优点就是小 30倍发行市盈率媲美云南白药",
    "href": "http://stock.jrj.com.cn/2020/08/18182730531352.shtml",
    "datetime": "2020-08-18 18:27:06",
    "code": "300878"
  },
  {
    "title": "今日新股申购：金春股份、维康药业、派克新材、天普股份、键凯科技",
    "href": "http://stock.jrj.com.cn/2020/08/13085330489213.shtml",
    "datetime": "2020-08-13 08:53:00",
    "code": "300878"
  },
  {
    "title": "维康药业今日申购 顶格申购需配市值5.5万元",
    "href": "http://stock.jrj.com.cn/ipo/2020/08/13080230489113.shtml",
    "datetime": "2020-08-13 08:02:49",
    "code": "300878"
  },
  {
    "title": "维康药业创业板发行定价41.34元/股：对应市盈率为30.51倍",
    "href": "http://stock.jrj.com.cn/2020/08/12155830482407.shtml",
    "datetime": "2020-08-12 15:58:27",
    "code": "300878"
  },
  {
    "title": "天普股份、派克新材、维康药业、金春股份8月13日申购宝典",
    "href": "http://stock.jrj.com.cn/ipo/2020/08/12153430482284.shtml",
    "datetime": "2020-08-12 15:34:25",
    "code": "300878"
  },
  {
    "title": "8月5日创业板动态：金春股份和维康药业将于8月7日询价 8月13日申购",
    "href": "http://stock.jrj.com.cn/2020/08/06140830441238.shtml",
    "datetime": "2020-08-06 14:08:25",
    "code": "300878"
  },
  {
    "title": "金春股份、维康药业披露上市安排：8月7日询价 8月13日申购",
    "href": "http://stock.jrj.com.cn/2020/08/05113230430766.shtml",
    "datetime": "2020-08-05 11:32:41",
    "code": "300878"
  },
  {
    "title": "[维康药业]维康药业党委副书记、维康医药零售董事长叶萍当选为丽水市慈善总会副会长",
    "href": "http://stock.jrj.com.cn/2020/07/01000030865647.shtml",
    "datetime": "2020-07-01 00:00:00",
    "code": "300878"
  },
  {
    "title": "[维康药业]维康药业喜获“致敬逆行者·2020全国医药企业、药店人榜样”两项大奖",
    "href": "http://stock.jrj.com.cn/2020/06/30000030865652.shtml",
    "datetime": "2020-06-30 00:00:00",
    "code": "300878"
  },
  {
    "title": "维康药业创业板试行注册制发行上市获得受理：2019年净利润为1.26亿元",
    "href": "http://stock.jrj.com.cn/2020/06/23150629999032.shtml",
    "datetime": "2020-06-23 15:06:31",
    "code": "300878"
  },
  {
    "title": "[维康药业]“维康爱心育才基金”再掀助学热,320名优秀学生获奖励~",
    "href": "http://stock.jrj.com.cn/2020/06/10000030865646.shtml",
    "datetime": "2020-06-10 00:00:00",
    "code": "300878"
  },
  {
    "title": "销售费用吃光利润：拟IPO的维康药业所有药品价格3年内翻翻 利润原地踏步",
    "href": "http://stock.jrj.com.cn/2019/08/26175328034708.shtml",
    "datetime": "2019-08-26 17:53:41",
    "code": "300878"
  },
  {
    "title": "浙江维康药业拟登陆创业板 保荐机构为国信证券",
    "href": "http://stock.jrj.com.cn/2017/05/19100422503196.shtml",
    "datetime": "2017-05-19 10:04:00",
    "code": "300878"
  }
]